184 related articles for article (PubMed ID: 17114082)
1. PET: other thoracic malignancies.
Quint LE
Cancer Imaging; 2006 Oct; 6(Spec No A):S82-8. PubMed ID: 17114082
[TBL] [Abstract][Full Text] [Related]
2. PET scan contribution in chest tumor management: a systematic review for thoracic surgeons.
Duranti L; Leo F; Pastorino U
Tumori; 2012; 98(2):175-84. PubMed ID: 22677982
[TBL] [Abstract][Full Text] [Related]
3. [18F]Fluorodeoxyglucose PET in Thoracic Malignancies.
Vilstrup MH; Torigian DA
PET Clin; 2014 Oct; 9(4):391-420, v. PubMed ID: 26050944
[TBL] [Abstract][Full Text] [Related]
4. Patterns of lymphadenopathy in thoracic malignancies.
Sharma A; Fidias P; Hayman LA; Loomis SL; Taber KH; Aquino SL
Radiographics; 2004; 24(2):419-34. PubMed ID: 15026591
[TBL] [Abstract][Full Text] [Related]
5. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
6. ¹⁸F-FDG uptake on PET could be a predictive marker of excision repair cross-complementation group 1 (ERCC1) expression in patients with thoracic neoplasms?
Kaira K; Endo M; Shukuya T; Kenmotsu H; Naito T; Ono A; Tsuya A; Nakamua Y; Takahashi T; Murakami H; Kondo H; Nakajima T; Yamamoto N
Neoplasma; 2012; 59(3):257-63. PubMed ID: 22329847
[TBL] [Abstract][Full Text] [Related]
7. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT in the management of primary pleural tumors and pleural metastases.
Kruse M; Sherry SJ; Paidpally V; Mercier G; Subramaniam RM
AJR Am J Roentgenol; 2013 Aug; 201(2):W215-26. PubMed ID: 23883236
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.
Sung YM; Lee KS; Kim BT; Choi JY; Shim YM; Yi CA
J Nucl Med; 2006 Oct; 47(10):1628-34. PubMed ID: 17015898
[TBL] [Abstract][Full Text] [Related]
10. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
[TBL] [Abstract][Full Text] [Related]
11. ¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms.
Kaira K; Yamamoto N; Endo M; Kenmotsu H; Naito T; Ono A; Murakami H; Ohde Y; Nakajima T; Takahashi T
Oncol Rep; 2014 Jan; 31(1):209-15. PubMed ID: 24173608
[TBL] [Abstract][Full Text] [Related]
12. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
[TBL] [Abstract][Full Text] [Related]
13. [Mesothelioma staging with ¹⁸F-FDG PET/CT. A case report with simultaneous pleural and peritoneal infiltration].
Moreno C; Soler M; Mourelo S; Moragas M; Riera E; Garcia JR
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):141-2. PubMed ID: 25049160
[No Abstract] [Full Text] [Related]
14. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma.
Schneider DB; Clary-Macy C; Challa S; Sasse KC; Merrick SH; Hawkins R; Caputo G; Jablons D
J Thorac Cardiovasc Surg; 2000 Jul; 120(1):128-33. PubMed ID: 10884665
[TBL] [Abstract][Full Text] [Related]
15. Is FDG-PET indicated for superficial esophageal cancer?
Little SG; Rice TW; Bybel B; Mason DP; Murthy SC; Falk GW; Rybicki LA; Blackstone EH
Eur J Cardiothorac Surg; 2007 May; 31(5):791-6. PubMed ID: 17337344
[TBL] [Abstract][Full Text] [Related]
16. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T
Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691
[TBL] [Abstract][Full Text] [Related]
17. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Pieterman RM; Que TH; Elsinga PH; Pruim J; van Putten JW; Willemsen AT; Vaalburg W; Groen HJ
J Nucl Med; 2002 Feb; 43(2):167-72. PubMed ID: 11850480
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography in the staging of esophageal cancer.
Leccisotti L
Rays; 2006; 31(1):9-12. PubMed ID: 16999368
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters.
Nowak AK; Francis RJ; Phillips MJ; Millward MJ; van der Schaaf AA; Boucek J; Musk AW; McCoy MJ; Segal A; Robins P; Byrne MJ
Clin Cancer Res; 2010 Apr; 16(8):2409-17. PubMed ID: 20371686
[TBL] [Abstract][Full Text] [Related]
20. Malignant pleural mesothelioma: utility of 18 F-FDG PET.
Spitilli MG; Treglia G; Calcagni ML; Giordano A
Ann Ital Chir; 2007; 78(5):393-6. PubMed ID: 18338546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
